Discovery of a VHL and HIF1α interaction inhibitor with in vivo angiogenic activity via structure-based virtual screening.
Chem Commun (Camb)
; 52(87): 12837-12840, 2016 Oct 25.
Article
en En
| MEDLINE
| ID: mdl-27709157
ABSTRACT
We describe herein compound 1, which is similar to many known natural products, as an inhibitor of the VHL-HIF1α interaction via structure-based virtual screening. Compound 1 disrupts VHL-mediated HIF1α degradation, leading to significantly increased VEGF expression. To our knowledge, compound 1 is a member of only the second class of small molecule inhibitors of the VHL-HIF1α interaction.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Conformación Proteica
/
Neovascularización Fisiológica
/
Proteína Supresora de Tumores del Síndrome de Von Hippel-Lindau
/
Subunidad alfa del Factor 1 Inducible por Hipoxia
/
Bibliotecas de Moléculas Pequeñas
/
Ensayos Analíticos de Alto Rendimiento
/
Mapas de Interacción de Proteínas
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Humans
Idioma:
En
Revista:
Chem Commun (Camb)
Asunto de la revista:
QUIMICA
Año:
2016
Tipo del documento:
Article
País de afiliación:
China